52-letni mężczyzna z przewlekłą chorobą niedokrwienną serca, nawracającymi dolegliwościami bólowymi w klatce piersiowej i upośledzoną tolerancją wysiłku Opis przypadku
##plugins.themes.bootstrap3.article.sidebar##
Opublikowane:
gru 31, 2011
##plugins.themes.bootstrap3.article.main##
Abstrakt
Brak
##plugins.themes.bootstrap3.article.details##
Jak cytować
Barylski , M. (2011). 52-letni mężczyzna z przewlekłą chorobą niedokrwienną serca, nawracającymi dolegliwościami bólowymi w klatce piersiowej i upośledzoną tolerancją wysiłku. Medycyna Faktów , 4(4(13), 59-65. Pobrano z https://www.journalsmededu.pl/index.php/jebm/article/view/2505
Numer
Dział
Artykuły
Copyright © by Medical Education. All rights reserved.
Bibliografia
1. Banasiak W., Pociupany R., Wilkins A. et al.: Pharmacotherapy in patients with stable coronary artery disease treated on an outpatient basis in Poland. Results of the multicentre RECENT study. Kardiol. Pol. 2008; 66: 642-649.
2. Fox K., Garcia M.A., Ardissino D. et al.: Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur. Heart J. 2006; 27(11): 1341-1381.
3. Detry J.M., Sellier P., Pennaforte S. et al.: Trimetazidine: a new concept in the treatment of angina. Comparison with propranolol in patients with stable angina. Trimetazidine European Multicenter Study Group. Br. J. Clin. Pharmacol. 1994; 37(3): 279-288.
4. Detry J.M., Leclercq P.J.: Trimetazidine European Multicenter Study versus propranolol in stable angina pectoris: contribution of Holter electrocardiographic ambulatory monitoring. Am. J. Cardiol. 1995; 76: 8B-11B.
5. Makolkin V.I., Osadchiy K.K.: Trimetazidine Modified Release in the Treatment of Stable Angina. TRIUMPH Study. Clin. Drug Invest. 2004; 24: 731-738.
6. Michaelides A.P., Spiropoulos K., Dimopoulos K. et al.: Antianginal Efficacy of the Combination of Trimetazidine-Propranolol Compared with Isosorbide Dinitrate – Propranolol in Patients with Stable Angina. Clin. Drug Invest. 1997; 13: 8-14.
7. Manchanda S.C., Krishnaswami S.: Combination treatment with trimetazidine and diltiazem in stable angina pectoris. Heart 1997; 78: 353-357.
8. Koylan N., Bilge A.K., Adalet K. et al.; TTS Group: Comparison of the effects of trimetazidine and diltiazem on exercise performance in patients with coronary heart disease. The Turkish trimetazidine study (TTS). Acta Cardiol. 2004; 59: 644-650.
9. Chaloupka V.: Trimetazidine in the treatment of stable angina pectoris TRIADA (trimetazidine in stable angina twice daily. Vnitr. Lek. 2006; 52: 609-614.
10. Chazov E.I., Lepakchin V.K., Zharova E.A. et al.: Trimetazidine in Angina Combination Therapy-The TACT Study: Trimetazidine versus Conventional Treatment in Patients with Stable Angina Pectoris in a Randomized, Placebo-Controlled, Multicenter Study. Am. J. Therap. 2005; 12: 35-42.
11. Lee L., Horowitz J., Frenneaux M.: Metabolic manipulation in ischaemic heart disease, a novel approach to treatment. Eur. Heart J. 2004; 25: 634-641.
12. Szwed H., Sadowski Z., Pachocki R. et al.: Anti-Ischaemic Efficacy and Tolerability of Trimetazidine in Elderly Patients with Angina Pectoris A Sub-Study from TRIMPOL-1 (Trimetazidine in Poland). Clin. Drug Invest. 2000; 19: 1-8.
13. Szwed H., Sadowski Z., Elikowski W. et al.: Combination treatment in stable effort angina using trimetazidine and metoprolol: results of a randomized, double-blind, multicentre study (TRIMPOL II). TRIMetazidine in POLand. Eur. Heart J. 2001; 22: 2267-2274.
14. Ciapponi A., Pizarro R., Harrison J.: Trimetazidine for stable angina. The Cochrane Database of Systematic Reviews 2005; 19: CD003614.
15. Iyengar S.S., Rosano G.M.: Effect of antianginal drugs in stable angina on predicted mortality risk after surviving a myocardial infarction: a preliminary study (METRO). Am. J. Cardiovasc. Drugs 2009; 9(5): 293-297.
2. Fox K., Garcia M.A., Ardissino D. et al.: Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur. Heart J. 2006; 27(11): 1341-1381.
3. Detry J.M., Sellier P., Pennaforte S. et al.: Trimetazidine: a new concept in the treatment of angina. Comparison with propranolol in patients with stable angina. Trimetazidine European Multicenter Study Group. Br. J. Clin. Pharmacol. 1994; 37(3): 279-288.
4. Detry J.M., Leclercq P.J.: Trimetazidine European Multicenter Study versus propranolol in stable angina pectoris: contribution of Holter electrocardiographic ambulatory monitoring. Am. J. Cardiol. 1995; 76: 8B-11B.
5. Makolkin V.I., Osadchiy K.K.: Trimetazidine Modified Release in the Treatment of Stable Angina. TRIUMPH Study. Clin. Drug Invest. 2004; 24: 731-738.
6. Michaelides A.P., Spiropoulos K., Dimopoulos K. et al.: Antianginal Efficacy of the Combination of Trimetazidine-Propranolol Compared with Isosorbide Dinitrate – Propranolol in Patients with Stable Angina. Clin. Drug Invest. 1997; 13: 8-14.
7. Manchanda S.C., Krishnaswami S.: Combination treatment with trimetazidine and diltiazem in stable angina pectoris. Heart 1997; 78: 353-357.
8. Koylan N., Bilge A.K., Adalet K. et al.; TTS Group: Comparison of the effects of trimetazidine and diltiazem on exercise performance in patients with coronary heart disease. The Turkish trimetazidine study (TTS). Acta Cardiol. 2004; 59: 644-650.
9. Chaloupka V.: Trimetazidine in the treatment of stable angina pectoris TRIADA (trimetazidine in stable angina twice daily. Vnitr. Lek. 2006; 52: 609-614.
10. Chazov E.I., Lepakchin V.K., Zharova E.A. et al.: Trimetazidine in Angina Combination Therapy-The TACT Study: Trimetazidine versus Conventional Treatment in Patients with Stable Angina Pectoris in a Randomized, Placebo-Controlled, Multicenter Study. Am. J. Therap. 2005; 12: 35-42.
11. Lee L., Horowitz J., Frenneaux M.: Metabolic manipulation in ischaemic heart disease, a novel approach to treatment. Eur. Heart J. 2004; 25: 634-641.
12. Szwed H., Sadowski Z., Pachocki R. et al.: Anti-Ischaemic Efficacy and Tolerability of Trimetazidine in Elderly Patients with Angina Pectoris A Sub-Study from TRIMPOL-1 (Trimetazidine in Poland). Clin. Drug Invest. 2000; 19: 1-8.
13. Szwed H., Sadowski Z., Elikowski W. et al.: Combination treatment in stable effort angina using trimetazidine and metoprolol: results of a randomized, double-blind, multicentre study (TRIMPOL II). TRIMetazidine in POLand. Eur. Heart J. 2001; 22: 2267-2274.
14. Ciapponi A., Pizarro R., Harrison J.: Trimetazidine for stable angina. The Cochrane Database of Systematic Reviews 2005; 19: CD003614.
15. Iyengar S.S., Rosano G.M.: Effect of antianginal drugs in stable angina on predicted mortality risk after surviving a myocardial infarction: a preliminary study (METRO). Am. J. Cardiovasc. Drugs 2009; 9(5): 293-297.